08 April 2021
Clinigen launches Managed Access Program with BeiGene for zanubrutinib

06 April 2021
Clinigen to begin supplying Erwinase® in the UK

01 April 2021
Enthera Pharmaceuticals appoints Claudia Nardini as Vice President of Research and Development

31 March 2021
Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use

30 March 2021
Leiden University Medical Center and Ixaka enter collaboration to strengthen knowledge of cell therapy candidate REX-001

29 March 2021
New report reveals links between Covid-19 and the microbiome

29 March 2021
Clinigen Joins Decentralized Trials & Research Alliance (DTRA)

25 March 2021
Scientific paper by NutriLeads shows that its plant-based RG-I food ingredients support immune function and modulate the microbiota

24 March 2021
Mission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan Hepple, to its Board of Directors

23 March 2021
Rutherford Health Plc - £40m Infrastructure Investment

23 March 2021
Oxford BioDynamics announces US launch of its EpiSwitch® COVID-19 Severity Test (CST)

22 March 2021
Ieso - largest ever analysis of digital mental health conversations reveals anxiety levels have continued to climb throughout the pandemic

18 March 2021
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook

17 March 2021
Oxford BioDynamics publishes results of biomarker discovery program being used for development of its EpiSwitch® Covid-19 Severity Test

17 March 2021
Forbion co-leads oversubscribed $53M Series B round for Amphista Therapeutics

16 March 2021
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington’s disease

15 March 2021
Clinigen signs distribution agreement with Amgen in territories across Africa and Asia

15 March 2021
SkinBioTherapeutics plc - Half year consolidated results

11 March 2021
Revolutionary anti-viral face mask kills 99.9% of Covid-19 virus on contact

11 March 2021
Touchlight raises £42M ($58M) to meet unprecedented global DNA demand

04 March 2021
Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine

04 March 2021
Autifony Therapeutics, Boehringer Ingelheim to collaborate on novel ion channel target with potential in multiple disease areas related to lysosomal storage disorders

04 March 2021
Ieso Appoints Jo Parfrey as a Non-Executive Director

01 March 2021
Forbion leads $37M financing for Oxular

24 February 2021
Microbiotica Appoints Hans Schikan as Independent Non-Executive Chairman

23 February 2021
Engitix Therapeutics strengthens management team with new directors for fibrosis and computational biology

23 February 2021
Clinigen - Half Year Results

18 February 2021
SkinBioTherapeutics plc - AxisBiotix-Ps™ food supplement consumer study commences

15 February 2021
Clinigen partners with Karyopharm to distribute XPOVIO® (selinexor) to patients outside of the United States as part of a Named Patient Program

10 February 2021
Forbion launches VectorY, a novel gene therapy company to develop innovative vectorized antibodies

10 February 2021
Launch of novel gene therapy company, VectorY, to develop innovative vectorized antibodies

09 February 2021
Seventure Partners - Health for Life Capital II™ fund, managed by Seventure Partners, makes two new immuno-oncology (I/O) investments

08 February 2021
Ixaka strengthens IP Portfolio for its in vivo gene delivery platform and multi-cell therapy with key European and US patents

04 February 2021
Microbiotica expands management team with appointments of Chief Medical Officer and Chief Operating Officer

04 February 2021
GHO appoints David Miller and Geoffrey Hamilton-Fairley as Operating Partners

01 February 2021
SkinBioTherapeutics plc - Expanded enrolment for AxisBiotix-Ps™ food supplement consumer study

28 January 2021
Enthera Pharmaceuticals extends Series A financing, raising a total of €35m

28 January 2021
Prilenia Enrolls First Subject in Europe in its PROOF-HD Phase 3 Clinical Trial for Huntington’s Disease

28 January 2021
Oxford Biodynamics Plc - Full Year Results

27 January 2021
VarmX appoints Dr. Gerard Short as Chief Medical Officer

26 January 2021
X-Chem acquires IntelliSyn and sister company, AviSyn, to extend and streamline drug discovery service range

26 January 2021
Clinigen receives marketing approval for Hunterase (Idursulfase-beta) ICV in Japan

21 January 2021
Xellia Pharmaceuticals joins Medicines for Europe to support better access to critical medicines

18 January 2021
Seventure Partners Life Sciences Corporate Update Health for Life: October - December 2020

18 January 2021
Ixaka (formerly Rexgenero) launches as an integrated cell and gene therapy company

14 January 2021
Forbion portfolio company, NewAmsterdam Pharma completes €160M Series A Funding for Phase 3 Development Program

14 January 2021
Clinigen Group plc - Half Year trading update

13 January 2021
SkinBioTherapeutics plc - Enrolment for AxisBiotix-Ps™ food supplement consumer study commences

11 January 2021
Health for Life Capital Fund, managed by Seventure Partners, increases focus on skin microbiome in its portfolio

08 January 2021
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial for ALS

08 January 2021
NorthSea Therapeutics - Positive Phase 2b ICONA interim results for icosabutate in NASH patients

07 January 2021
BioGeneration Ventures BGV IV fund closes at €140 million

07 January 2021
Synthon BV Appoints Anish Mehta as Chief Executive Officer and Member of the Board of Directors